IGF2BP1 and embryonal rhabdomyosarcoma: In the context of RMS, it was recently shown that IGF2BP1 regulates translation of mRNAs encoding cellular inhibitor of apoptosis 1 (cIAP1) thus impacting ERMS cell survival and drug resistance53.